Predicting Lymph Node Metastasis In Operable Cervical Cancer Patients: Can We Identify Patients At Risk For Dual Surgical And Radiotherapeutic Treatments?

ESGO eAcademy, Nuria Garcia, 4151632

The Role of Molecular (and Non-molecular) Biomarkers in Tayloring Endometrial Cancer Medical Treatment in Advanced and Metastatic Disease

ESGO eAcademy, Domenica Lorusso, 4151627

Patterns, Risk Factors And The Impact Of Concomitant Cisplatin On Distant Metastasis In Locally Advanced Cervical Cancer – An EMBRACE I Analysis

ESGO eAcademy, Johannes Knoth, 4151631

Minimally Invasive Surgery for Low-risk Cervical Cancer: Not So Fast! (Against MIS)

ESGO eAcademy, Pedro Ramirez, 4151624

Radical Trachelectomy For Early Stage Cervical Cancer In The Netherlands: A Nationwide Cohort Study On Long-Term Oncologic, Fertility, And Obstetric Outcomes.

ESGO eAcademy, Yaël Stroeken, 4151630

Is There a Role for Molecular (and other) Biomarkers in Guiding Surgical Treatment in Endometrial Cancer?

ESGO eAcademy, Philipp Harter, 4151626

Uncovering The Disease Biology Of HPV Persistence - An Examination Of Proteomics In The UK Biobank

ESGO eAcademy, Blanche Francheterre, 4151629

Early-STage CERvical CaNcer Undergoing For FertilItY-Sparing Approach: Long-Term Outcomes From The ETERNITY Project

ESGO eAcademy, Giorgio Bogani, 4151628

Predictive and Prognostic Biomarkers and It’s Therapeutic Role in Early Stage

ESGO eAcademy, Antonio Gonzalez Martin, 4151625

Why Not Offer the Best Approach to Patients with Low-risk Cervical Cancer? (For MIS)

ESGO eAcademy, René Pareja, 4151623

Uterine Sarcoma Mobile App Update

ESGO eAcademy, Enora LAAS, 4151622

The Role of the PAP Test in the Prevention of Ovarian and Endometrial Cancer

ESGO eAcademy, Silvia Cabrera, 4151613

Gynaecological Cancers at AYA Age: Consequences on Daily Life at the Short and Long-term

ESGO eAcademy, Winette van der Graaf, 4151618

Challenges when Ovarian Cancer Complicates Pregnancy

ESGO eAcademy, Frederic Amant, 4151617

ESGO Consensus Statement on Prevention, Risk Reduction Strategies and Management of Women with Hereditary Predisposition to Ovarian Cancer

ESGO eAcademy, Claudia Marchetti, 4151612

How Molecular Analysis Can Help Managing Uterine Sarcoma Patients - A Practical Approach with Real Life Cases

ESGO eAcademy, Sabrina Croce, 4151620

ESGO Consensus Statement on Endometrial Cancer Prevention, Risk Reduction Strategies, and Management of Women with Lynch Syndrome

ESGO eAcademy, Murat Gultekin, 4151611

Role of Surgery in Uterine Sarcomas: ESGO Recommendations

ESGO eAcademy, Ignacio Zapardiel, 4151619

Cervical Cancer in AYA Patients

ESGO eAcademy, Zoltan Novak, 4151616

Best Oral session: Discussant - why is quality of life important?

ESGO eAcademy, Jalid Sehouli, 4151603

Fertility Sparing Management in Gestational Trophoblastic Disease

ESGO eAcademy, Nikolaos Thomakos, 4151606

Health-Related Quality Of Life After Risk-Reducing Hysterectomy: A Cross-Sectional Study Of Women With Lynch Syndrome

ESGO eAcademy, Sam Oxley, 4151602

Case Presentation - Non-dMMR Endometrial cancer

ESGO eAcademy, Tullia Rushton, 4151608

COmplications And REcurrence After Pelvic Exenteration For Gynecologic Malignancies: Analysis Of Surgical Complications From The COREPEX Study.

ESGO eAcademy, Nicolò Bizzarri, 4151601

Fertility Sparing Treatment for Stage III Ovarian Serous Borderline Tumour

ESGO eAcademy, Philippe Morice, 4151605

Discussant - Non-dMMR Endometrial Cancer

ESGO eAcademy, Mansoor Raza Mirza, 4151609

The Impact Of The LETSGO Personalized Follow-Up Model On Empowerment And Quality Of Life In Gynaecological Cancer Survivors: A Multicenter Quasi-Experimental Study

ESGO eAcademy, Ingvild Vistad, 4151600

Case Presentation - Non-MMRd Endometrial Cancer

ESGO eAcademy, Richard Schwameis, 4151607

Fertility Sparing Treatment for Endometrial Cancer

ESGO eAcademy, Nadeem R. Abu-Rustum, 4151604

Quality-Adjusted Time Without Symptoms Of Disease Progression Or Toxicity Analysis Of Mirvetuximab Soravtansine Versus Investigator’s Choice Of Chemotherapy In Folate Receptor-Alpha Positive, Platinum-Resistant Ovarian Cancer

ESGO eAcademy, Felix Hilpert, 4151599

Panel discussion and audience Q&A

ESGO eAcademy, Domenica Lorusso, 4151598

Introducing ADCs into Clinical Practice: What Do We Need to Anticipate?

ESGO eAcademy, Susana Banerjee, 4151597

What Could Be the Options of Post Immunotherapy?

ESGO eAcademy, Sandro Pignata, 4151593

Biomarker testing in advanced OC: what do we need to test for now?

ESGO eAcademy, Elena Ioanna Braicu, 4151596

Chemo Free Treatment in Endometrial Cancer

ESGO eAcademy, Christian Marth, 4151592

Treatment Landscape in Endometrial Cancer

ESGO eAcademy, Isabelle Ray-Coquard, 4151591

Four Live Scans and Clinical Cases

ESGO eAcademy, Antonia Carla Testa, 4151590

Parametrial Assessment and Pelvic Side Wall Assessment

ESGO eAcademy, Antonia Carla Testa, 4151589

Systematic Approach for Cervical Cancer Staging

ESGO eAcademy, Daniela Fischerova, 4151588

Introduction of Ultrasound in Cervical Cancer, including Scientific Results and Role in Current Guidelines (ESGO/ESTRO/ESP, FIGO)

ESGO eAcademy, Elisabeth Epstein, 4151587

ASGO - ESGO 3rd Joint Webinar: Multidisciplinary Guidelines for the Management of Uterine Sarcomas

ESGO eAcademy, Faculty / Presenter(s), 4151900

Patient advocacy

ESGO eAcademy, Faculty / Presenter(s), 4151918

Vaginal and Vulvar Cancer

ESGO eAcademy, Faculty / Presenter(s), 4151917

Ovarian cancer

ESGO eAcademy, Faculty / Presenter(s), 4151916

Endometrial cancer

ESGO eAcademy, Faculty / Presenter(s), 4151915

Cervical cancer

ESGO eAcademy, Faculty / Presenter(s), 4151914

DDI - Ovarian cancer

ESGO eAcademy, Faculty / Presenter(s), 4151340

DDI - Vulvar cancer

ESGO eAcademy, Faculty / Presenter(s), 4151339

DDI - Uterine cancer

ESGO eAcademy, Faculty / Presenter(s), 4151338

DDI - Cervical cancer

ESGO eAcademy, Faculty / Presenter(s), 4151337

Meet the Surgeon: From lymhadenectomy to SN in vulvar cancer by Ate Van der Zee

ESGO eAcademy, Faculty / Presenters, 4147949

Seeking Equality in Surgery: Do we blame the Tools?

ESGO eAcademy, Faculty / Presenters, 4147825

Tumour board 16: Current development and controversies in Endometrial Cancer

ESGO eAcademy, Faculty / Presenter(s), 4151183

Vulvar and vaginal cancer epidemiology and screening

ESGO eAcademy, Faculty / Presenter(s), 4150732

Debates in EC Management: How to choose First-Line therapy for your metastatic EC patient

ESGO eAcademy, Faculty / Presenter(s), 4150267

4th webinar: Leadership training: What women need to know

ESGO eAcademy, Faculty / Presenter(s), 4150693

The Challenge of sparing the uterus in pelvic oncology by Reitan Ribeiro

ESGO eAcademy, Faculty / Presenter(s), 4150261

ASGO - ESGO 2nd Joint Webinar on The Role of Surgery in Recurrent Ovarian Cancer in the Era of Targeted Therapy

ESGO eAcademy, Faculty / Presenter(s), 4150064

Simplifying Type C1 Radical Hysterectomy by following the Hypogastric Nerve Plate-Line

ESGO eAcademy, Ilker Selcuk, 4148054

Selective Systematic Nerve-Sparing Type C2 Radical Hysterectomy (Type C2N, Selcuk Technique for Nerve-Sparing Radical Hysterectomy)

ESGO eAcademy, Ilker Selcuk, 4148053

ENYGO&YEARS: Robotic radical hysterectomy - my way

ESGO eAcademy, Faculty / Presenter(s), 4150695

Paraaortic Lymphadenectomy

ESGO eAcademy, Faculty / Presenter(s), 4147953

Colpectomy

ESGO eAcademy, Jorge Ariel Perez, 4147658

3rd webinar: How can I integrate my family life with my career? How can/should employers and colleagues support this balance?

ESGO eAcademy, Faculty / Presenter(s), 4147213

Endometrial cancer prevention

ESGO eAcademy, Faculty / Presenter(s), 4145883

Palliative surgery by Giovanni Aletti

ESGO eAcademy, Faculty / Presenter(s), 4145758

Tumor board 15: Locally advanced cervical cancer

ESGO eAcademy, Faculty / Presenter(s), 4142466

New FIGO classification of endometrial cancers

ESGO eAcademy, Faculty / Presenter(s), 4142501

Multidisciplinary Tumour Board Dialogues – Endometrial cancer – Clinical cases discussions - June 29th, 2024

ESGO eAcademy, Faculty / Presenter(s), 4140553

Multidisciplinary Tumour Board Dialogues – Endometrial cancer – Clinical cases discussions - June 28th, 2024

ESGO eAcademy, Faculty / Presenter(s), 4140552

ASGO - ESGO 1st Joint Webinar on Fertility Preservation in gyneacologic cancers

ESGO eAcademy, Faculty / Presenter(s), 4140549

2nd webinar: But what is harassment?

ESGO eAcademy, Faculty / Presenter(s), 4139872

Technique of Radical Hysterectomy

ESGO eAcademy, Faculty / Presenter(s), 4139871

SESSION 1- Understanding the magnitude of the disease

ESGO eAcademy, Faculty / Presenter(s), 4136521

SESSION 2: Prevention of cervical cancer in Africa

ESGO eAcademy, Faculty / Presenter(s), 4136522

SESSION 3: Colposcopy and diagnosis

ESGO eAcademy, Faculty / Presenter(s), 4136523

SESSION 4: Risk-stratified treatment for pre-invasive and invasive carcinoma for LMIC

ESGO eAcademy, Faculty / Presenter(s), 4136524

HPV prevention in pregnancy

ESGO eAcademy, Faculty / Presenter(s), 428502

1st Webinar: We are all gender biased. So what?

ESGO eAcademy, Faculty / Presenter(s), 424836

A practical movie of an ERAS program by Pedro Ramirez

ESGO eAcademy, Faculty / Presenter(s), 422448

Lymph node assessment in vulvar cancer – VITA consensus

ESGO eAcademy, Faculty / Presenter(s), 418988

Tumour board 14: Cervial Cancer in Pregnancy

ESGO eAcademy, Faculty / Presenter(s), 417394

Exposure and paraaortic lymphadenectomy in patients with BMI > 40.

ESGO eAcademy, Hubert Fornalik, 412380

Invitation to ESGO 2025 in Rome

ESGO eAcademy, Anna Fagotti, 411169

Young Investigator Award

ESGO eAcademy, Nicole Concin, 411168

Best Runners Awards

ESGO eAcademy, Nicole Concin, 411167

Summary of the Congress

ESGO eAcademy, Nicole Concin, 411166

SUCCOR 10 Years: Vision A Decade After Radical Surgery As Primary Treatment For Cervical Cancer.

ESGO eAcademy, Nabil Manzour Sifontes, 411161

Total Mesometrial Resection: Open Surgical Technique

ESGO eAcademy, Selçuk Erkilinç, 411155

Management of Late Urinary Complications

ESGO eAcademy, Giuseppe Vizzielli, 411165

Tumor Treating Fields (TTFields) therapy in platinum-resistant ovarian cancer: Results from the ENGOT-ov50 / GOG-3029 / INNOVATE-3 phase 3 study

ESGO eAcademy, Ignace Vergote, 411159

Boari Flap Technique In Urinari Reconstruction In Gynecological Cancer

ESGO eAcademy, Marta de la Cruz, 411153

Principle of Bladder Reconstruction and Urinary Diversion

ESGO eAcademy, Gwenael Ferron, 411164

Discussant - LEAP 001 trail

ESGO eAcademy, Domenica Lorusso, 411157

Laparoscopic Extraperitoneal Debulking Of Enlarged Para-Aortic Lymph Node In Patient With Endometrial Carcinoma Recurrence.

ESGO eAcademy, Andrea Ungredda, 411152

How to Manage Intraoperatively a Ureteral Injury?

ESGO eAcademy, Giovanni Aletti, 411163

Lenvatinib Plus Pembrolizumab Versus Chemotherapy As First-Line Therapy For Advanced Or Recurrent Endometrial Cancer: Primary Results Of The Phase 3 ENGOT-en9/LEAP-001 Study

ESGO eAcademy, Christian Marth, 411156

V-NOTES Sentinel Lymph Node Mapping For Endometrial Carcinoma

ESGO eAcademy, Selçuk Erkilinç, 411151

ESGO Gynae-Cancers Algorithms App Presentation

ESGO eAcademy, Enora LAAS, 411144

Mucinous Ovarian Cancer, What We Have to Know Now and in the Future

ESGO eAcademy, Jonathan Ledermann, 411143